Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Articles

PDA works with FDA to create pharmaceutical quality metrics.

Large Industry Cross-Section Contributes to PDA Quality Metrics Recommendations

Eric Langer has over 25 years experience in biotechnology and life sciences strategic marketing management, market research, and publishing. He has held senior management and marketing positions at biopharmaceutical supply companies. He has published and authored many books and reports on topics in Biotechnology, Large-scale BioManufacturing, and bioscience commercialization and communication. He teaches at Johns Hopkins University marketing management, biotech marketing, services marketing, and marketing in a regulated environment. In 1989 he co-founded BioPlan Associates, Inc. to provide market analysis, and strategy to biotech and healthcare organizations.

CMOs may find opportunities in alternative expression services.

Novel Expression Systems Opening CMO Opportunities

Adeline Siew is editor for Pharmaceutical Technology Europe. She is also science editor for Pharmaceutical Technology.

Experts discuss factors affecting drug delivery to the lungs and key considerations when developing inhalation formulations.

Pulmonary Drug Delivery—Particle Engineering for Inhaled Therapeutics

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Automated sample handling, advanced glycan analysis, and specially designed columns are help speed up confirmation of the biosimilarity.

Advances in UPLC Techniques and Column Chemistry Aid the Confirmation of Biosimilarity

A changing biopharmaceutical industry is going beyond typically outsourced activities and is using CMOs for more challenging processes. Review the top 10 outsourcing trends.

Outsourcing Trends in Biopharmaceutical Manufacturing

Melanie Sena is community editor of Pharmaceutical Technology.

PharmaCell enters an agreement purchase TiGenix therapy production facility.

PharmaCell to Purchase Cell Therapy Production Facility from TiGenix

I Holland announces service that predicts solutions for tablet sticking problems.

Service Predicts Tablet Tooling Sticking Problems

With numerous biologics set to come off patent soon and the percentage of new therapeutics based on biomolecules growing, demand for contract manufacturing in the biopharma space is heating up.

Will CMOs Provide Sufficient Capacity for Growing Biologics Demand?

Novozymes Biopharma has released new study data on extending the serum half-life of albumin in vivo.

Novozymes Biopharma's Technology Demonstrates Potential for Monthly Drug Dosing

Products enable testing in accordance with methods described in new USP monograph.